XML 42 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation
STOCK-BASED COMPENSATION

We account for stock-based compensation under the fair value recognition provisions of ASC Topic 718 - Compensation - Stock Compensation. We recognize stock-based compensation cost over the award’s requisite service period on a straight-line basis for time-based restricted stock grants and performance-based restricted stock grants. We record forfeitures as they occur for all stock-based compensation.

Under the Company’s 2013 Omnibus Incentive Plan, 1,000,000 shares were authorized for issuance at December 31, 2019.

The following table presents our total stock-based compensation expense:

 
Year ended December 31,
 
2019
 
2018
 
2017
Employee stock-based compensation expense
 
 
 
 
 
     Pre-tax (1)
$
2,019

 
$
1,095

 
$
1,616

     Post-tax (2)
1,595

 
865

 
1,277

Director stock-based compensation expense
 
 
 
 
 
     Pre-tax (1)
988

 
1,319

 
996

     Post-tax (2)
781

 
1,042

 
787


(1) This table does not include withholding of vested shares for tax liabilities, which totaled $296,000, $418,000, and $287,000 in 2019, 2018, and 2017, respectively.
(2) The after tax amounts are determined using the 21% corporate federal tax rate.


We had approximately $3,560,000 of unrecognized stock compensation expense at December 31, 2019 related to non-vested stock-based compensation granted, which we expect to recognize over a weighted-average period of approximately 1.9 years. We had approximately $246,000 of unrecognized director stock-based compensation expense at December 31, 2019 related to non-vested director stock-based compensation granted, which we expect to recognize over a weighted-average period of approximately 0.4 years.

Restricted stock, restricted stock units and performance stock units

Stock-based compensation cost for restricted stock awards, restricted stock units and performance stock units is measured based on the closing fair market value of our common stock on the date of grant, which vest in equal installments over the requisite service period of typically three years. Restricted stock awards granted to non-employee directors vest over a one-year period. Each restricted stock unit and performance stock unit represents our obligation to deliver to the holder one share of common stock upon vesting.

Performance stock units vest based on the Company’s return on average equity compared to a defined group of peer companies. On the grant date, we issue the target number of performance stock units. They are subject to forfeitures if performance goals are not met. The actual number of performance stock units earned can vary from zero to 150 percent of the target for the 2018 and 2019 awards.

We granted 134,231, 174,602, and 167,622 shares of restricted common stock, which had a weighted-average grant date fair value of $16.24, $20.07, and $15.62 per share during the years ended December 31, 2019, 2018, and 2017, respectively. Additionally, during the year ended December 31, 2019, the Company granted 45,000 shares of restricted common stock, with a fair value of $15.70 per share, which is contingent upon stockholder approval of the 2020 Omnibus Incentive Plan. Stockholders will vote on this matter at our 2020 annual meeting of stockholders.

The following table presents certain information related to the activity of our non-vested common stock grants:

 
Number of Restricted Shares
 
Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2016
169,642

 
$
16.87

Granted
167,622

 
15.62

Less: Forfeited
17,537

 
14.07

Less: Vested
107,633

 
16.24

Outstanding as of December 31, 2017
212,094

 
$
16.44

Granted
174,602

 
20.07

Less: Forfeited
21,502

 
18.82

Less: Vested
147,258

 
16.68

Outstanding as of December 31, 2018
217,936

 
$
18.96

Granted (1)
134,231

 
16.24

Less: Forfeited
6,059

 
20.15

Less: Vested
131,613

 
19.22

Outstanding as of December 31, 2019
214,495

 
$
17.49


(1) Contingent shares have been excluded from the calculations in the table above.

Stock options

Stock option fair value was estimated on the grant date using the Black-Scholes-Merton formula. Stock options vest in equal installments over the requisite service period of typically three years. The following weighted-average assumptions were used to value the stock options granted:

 
2019
Expected annual dividend yield
1.28
 %
Expected volatility
41.07
 %
Risk-free interest rate
3.11
 %
Expected term
6
 years


Expected annual dividend yield is based on the current quarterly dividend of $0.06 per share and the stock price on the grant date. The expected volatility is a historical volatility calculated based on the daily closing prices over a period equal to the expected term. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date. Expected term takes into account the three-year graded vesting term and the 10-year contractual term of the option.

We granted 99,181 stock options during the year ended December 31, 2019, which had a weighted average grant date fair value of $5.96 per share. We granted 107,888 stock options during the year ended December 31, 2018 which had a weighted-average grant date fair value of $8.26 per share.


The following table presents certain information related to the activity of our non-vested stock option grants:

 
Number of Stock Options
 
Weighted Average Exercise Prices
 
Weighted Average Remaining Contractual Term (years)
 
Aggregate Intrinsic Value
Outstanding as of December 31, 2017

 
$

 

 
$

Granted
107,888

 
20.94

 

 

Less: Forfeited

 

 

 

Less: Exercised

 

 

 

Outstanding as of December 31, 2018
107,888

 
$
20.94

 
9.76

 
$

 
 
 
 
 
 
 
 
Vested as of December 31, 2018

 
$

 

 
$

Exercisable as of December 31, 2018

 
$

 

 
$

 
 
 
 
 
 
 
 
Outstanding as of December 31, 2018
107,888

 
$
20.94

 

 
$

Granted
99,181

 
16.25

 

 

Less: Forfeited

 

 

 

Less: Exercised

 

 

 

Outstanding as of December 31, 2019
207,069

 
$
18.69

 
9.00

 
$

 
 
 
 
 
 
 
 
Vested as of December 31, 2019
35,965

 
$
20.94

 
8.76

 
$

Exercisable as of December 31, 2019
35,965

 
$
20.94

 
8.76

 
$